Titan Medical Inc. (TMDI): Price and Financial Metrics
GET POWR RATINGS... FREE!
TMDI Stock Price Chart Interactive Chart >
TMDI Price/Volume Stats
|Current price||$1.64||52-week high||$3.47|
|Prev. close||$1.70||52-week low||$0.57|
|Day high||$1.72||Avg. volume||2,741,135|
|50-day MA||$1.71||Dividend yield||N/A|
|200-day MA||$1.55||Market Cap||179.63M|
Titan Medical Inc. (TMDI) Company Bio
Titan Medical Inc. is developing a 3-armed robotic surgical system to permit surgeons to remotely manipulate surgical instruments.
TMDI Latest News Stream
|Loading, please wait...|
TMDI Latest Social Stream
View Full TMDI Social Stream
Latest TMDI News From Around the Web
Below are the latest news stories about Titan Medical Inc that investors may wish to consider to help them evaluate TMDI as an investment opportunity.
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the voting results from the company’s Annual and Special Meeting of its Shareholders held on Wednesday, June 9, 2021.
Thinking about buying stock in Vertex Energy, AMC Entertainment, Iterum Therapeutics, Yext Inc, or Titan Medical?
NEW YORK , May 28, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VTNR, AMC, ITRM, YEXT, and TMDI.
Titan Medical Inc (NASDAQ: TMDI) has received million under the second technical milestone under the development and license agreement with Medtronic plc (NYSE: MDT). The development and license agreement provides for developing robotic-assisted surgical technologies for Titan and Medtronic in their respective businesses. Titan retains worldwide rights to commercialize the developed technologies for use with its own Enos robotic single access surgical system. In October 2020, Titan achieved the first technical milestone and completed a non-technical financial milestone under the development agreement, with the satisfactory raising of $18 million capital. Titan would receive an additional payment of approximately $11 million on completing the third technical milestone, representing the f...
Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement
Completion of Second Technical Milestone Marks Third Achievement Under Development and License AgreementTORONTO, May 28, 2021 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed the second technical milestone under the development and license agreement with Medtronic plc (NYSE: MDT), and received a U.S. $10 million payment for licensing the developed technologies to Medtronic. The development and license agreement provides for the development of robotic-assisted surgical technologies for use by both Titan and Medtronic in their respective businesses. Titan retains world-wide rights to commercialize the developed tec...
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces financial results for the three months ended March 31, 2021. During the first quarter of 2021 the company raised proceeds of $34.5 million from two equity financings and $10 million from the exercise of warrants issued to investors in previous offerings. Titan also announces changes to its board of directors appointing Paul Cataford as Chairman of the Board and Heather Knight as an independent member of the board. In addition, Cathy Steiner has been nominated for election to the Board at the annual and special meeting of shareholders on June 9, 2021.
TMDI Price Returns